Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03181048 · ClinicalTrials.gov registry record · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
A NA study of Hip Dysplasia, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 106
- Enrollment target
- 1
- Study location
NCT03181048: Recruiting NA study of Hip Dysplasia, sponsored by Mayo Clinic.
NCT03181048 is a NA study of Hip Dysplasia that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 106 participants, below the 186-participant average among 5 other Hip Dysplasia trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03181048, a NA study of Hip Dysplasia, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will assess the outcomes of patients treated with concomitant hip arthroscopy at the time of periacetabular osteotomy (PAO) for patients with hip dysplasia compared with patients treated with PAO alone.
Primary Outcome
Score ranges from 0-100 with higher scores representing better function.
Conditions Studied
Interventions
- PROCEDURE Periacetabular osteotomy
- PROCEDURE Periacetabular osteotomy with hip arthroscopy
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2017-08-23 |
| Est. Completion | 2028-06 |
| Phase | NA |
What NCT03181048 shows while recruiting
NCT03181048 is an interventional study that assigns participants to a tested intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap, below the 186-participant average among 5 other Hip Dysplasia trials with a reported enrollment target (43% lower).
The record links to 1 condition, with Hip Dysplasia appearing as the primary indexed condition, and to 2 interventions - of which Periacetabular osteotomy is the first listed.
NCT03181048 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03181048 about?
NCT03181048 is a clinical study titled "Clinical Trial of Concomitant Hip Arthroscopy During PAO". The study will assess the outcomes of patients treated with concomitant hip arthroscopy at the time of periacetabular osteotomy (PAO) for patients with hip dysplasia compared with patients treated with PAO alone.
What is the current status of trial NCT03181048?
This trial is currently recruiting. It is a NA study. The enrollment target is 106 participants. The study started on 2017-08-23. Estimated completion is 2028-06.
What conditions does trial NCT03181048 study?
This clinical trial studies the following conditions: Hip Dysplasia.
What interventions are being tested in trial NCT03181048?
The interventions under investigation include: Periacetabular osteotomy (PROCEDURE), Periacetabular osteotomy with hip arthroscopy (PROCEDURE).
Who is sponsoring clinical trial NCT03181048?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03181048 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of Cartilage Defect Repair
RECRUITING · NA
-
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
RECRUITING · NA
-
Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy
RECRUITING · Phase 4
-
Can PLIA Reduce Early Post-operative Pain After PAO Surgery?
RECRUITING · Phase 2
-
Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
- NCT04914507 · 106 participants · NA
A Prospective Analysis of Long-Term Clinical Outcomes and 3D Spine Growth in Anterior Vertebral Body Tethering
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI